Renexxion Ireland Ltd. Announces Issuance of Fifth New U.S. Patent Covering Novel Crystal Isoform of Naronapride
November 26, 2024 08:00 ET
|
RENEXXION IRELAND
Renexxion Ireland Ltd marks a major milestone in its intellectual property portfolio.